» Articles » PMID: 34529727

Spatio-temporal Characteristics of the Novel Coronavirus Attention Network and Its Influencing Factors in China

Overview
Journal PLoS One
Date 2021 Sep 16
PMID 34529727
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The outbreak of a novel coronavirus pneumonia (COVID-19), wherein more than 200 million people have been infected and millions have died, poses a great threat to achieving the United Nations 2030 sustainable development goal (SDGs). Based on the Baidu index of 'novel coronavirus', this paper analyses the spatial and temporal characteristics of and factors that influenced the attention network for COVID-19 from January 9, 2020, to April 15, 2020. The study found that (1) Temporally, the attention in the new coronavirus network showed an upward trend from January 9 to January 29, with the largest increase from January 23 to January 29 and a peak on January 29, and then a slow downward trend. The level of attention in the new coronavirus network was basically flat when comparing January 22 and March 4. (2) Spatially, first, from the perspective of regional differences, the network attention in the eastern and central regions decreased in turn. The network users in the eastern region exhibited the highest attention to the new coronavirus, especially in Guangdong, Shandong, Jiangsu and other provinces and cities. The network attention in Tibet, Xinjiang, Qinghai and Ningxia in the western region was the lowest in terms of the national network attention. Second, from the perspective of interprovincial differences, the attention in the new coronavirus network was highly consistent with the Hu Huanyong line of China's population boundary. The east of the Hu Huanyong line is densely populated, and the network showed high concern, mostly ranking at the third to fifth levels. (3) The number of Internet users in the information technology field, the population, and the culture and age characteristics of individuals are important factors that influence the novel coronavirus attention network.

Citing Articles

Spatiotemporal dynamic and regional differences of public attention to vaccination: An empirical study in China.

Zhang Y, Guo X, Su Y PLoS One. 2024; 19(12):e0312488.

PMID: 39715251 PMC: 11666014. DOI: 10.1371/journal.pone.0312488.


Spatiotemporal characteristics and influencing factors of network attention to resort hotels in China.

Sun H, Zhang Y, Guo W Heliyon. 2024; 10(15):e35314.

PMID: 39165937 PMC: 11333890. DOI: 10.1016/j.heliyon.2024.e35314.


Public network attention to hiking in China and its influencing factors.

Zhang Q, Sun H, Lin Q, Lin K, Chong K PLoS One. 2024; 19(7):e0306726.

PMID: 38991020 PMC: 11239110. DOI: 10.1371/journal.pone.0306726.


Seeing the forest and the trees: Holistic view of social distancing on the spread of COVID-19 in China.

Yu D, Zhang Y, Meng J, Wang X, He L, Jia M Appl Geogr. 2023; 154:102941.

PMID: 37007437 PMC: 10040366. DOI: 10.1016/j.apgeog.2023.102941.


Using search trends to analyze web-based users' behavior profiles connected with COVID-19 in mainland China: infodemiology study based on hot words and Baidu Index.

Jiang S, You C, Zhang S, Chen F, Peng G, Liu J PeerJ. 2022; 10:e14343.

PMID: 36389414 PMC: 9653070. DOI: 10.7717/peerj.14343.

References
1.
Sayeed S, Faiz B, Aslam S, Masood L, Saeed R . CT Chest Severity Score for COVID 19 Pneumonia: A Quantitative Imaging Tool for Severity Assessment of Disease. J Coll Physicians Surg Pak. 2021; 31(4):388-392. DOI: 10.29271/jcpsp.2021.04.388. View

2.
Rischin A, Liew D, Black R, Fletcher A, Buchbinder R, Lassere M . Healthcare access and attitudes towards telehealth during the early phase of the COVID-19 pandemic among an Australian cohort with inflammatory arthritis. Intern Med J. 2021; 51(5):788-792. PMC: 8207000. DOI: 10.1111/imj.15309. View

3.
Bernstein D, Richardson M, Hammert W . Assessing Factors Associated With Altmetric Attention Score: A Preliminary Study of 3 Hand Surgery Journals. Hand (N Y). 2021; 17(6):1242-1249. PMC: 9608305. DOI: 10.1177/15589447211017220. View

4.
DeMets D, Fleming T . Achieving effective informed oversight by DMCs in COVID clinical trials. J Clin Epidemiol. 2020; 126:167-171. PMC: 7351066. DOI: 10.1016/j.jclinepi.2020.07.001. View

5.
Lefrancq N, Paireau J, Hoze N, Courtejoie N, Yazdanpanah Y, Bouadma L . Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: A retrospective national surveillance data analysis. Lancet Reg Health Eur. 2021; 5:100087. PMC: 7981225. DOI: 10.1016/j.lanepe.2021.100087. View